Meningitis: Vaccination
(asked on 17th March 2015) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, pursuant to the Answer of 11 March 2015 to Question 226346, when he expects negotiations with GlaxoSmithKline on the meningitis B vaccine to be concluded.
This question was answered on 24th March 2015
We are seeking to reach a positive conclusion to the negotiations with GlaxoSmithKline for supply of the meningococcal B (MenB) vaccine, Bexsero® at a cost-effective price, as recommended by the Joint Committee on Vaccination and Immunisation, as soon as possible.
The Department has had a number of meetings with the manufacturer and is continuing to meet.